Sitemap - June, 2005 - Medical Marketing and Media

Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Email*

Password*

Keep me logged in Forgot your password?

Email*

June, 2005:

Canada to ban bulk drug sales to prevent shortages

Celebrex scripts see decline

FDA warns on Endo direct mail pieces

FDA ups effort in search for drug safety director

FDA finds safety concerns with J&J attention-deficit drug

Millennium announces new chief executive

Drug co-pay to hit $100

Watchdog group to monitor DDMAC

Pfizer denies Viagra blindness risk

House votes to bar public funding for ED drugs

Biogen IDEC sells off Tysabri plant

FDA approves first ethnically targeted drug

Merck tried to reformulate Vioxx in 2000 to make it safer

Pfizer invites agencies to pitch for Lipitor consumer work

Plan-B legislation wins approval in New York

Dole kicks off second leg of Medicare drug benefit speaking tour

AMA votes to further study DTC advertising

PhRMA launches Web site highlighting re-importation risks

Former Pfizer CRM head joins renamed Omnicom unit

Wyeth to cut sales force by up to 30 percent

Agency People news from the 6/17 News Brief

Manufacturer People News from the 6/17 News Brief

BBDO brought on board to handle Levitra project work

FDA panel recommends drug strictly for African-Americans

Crawford faces obstacles in nomination process

Big pharma gets a lift, biotechs hurt by patent ruling

Crestor loses market share following AHA journal article

MBC hires former Cadient duo Douglass and Burke

New California law mandates adherence to voluntary codes

AMA rebranding with $20 million campaign

Pfizer to buy Vicuron Pharmaceuticals for $1.9 billion

BMS bars DTC on new drugs

Experts say J&J should restrict Natrecor use to sickest patients

Insurer advocates pill splitting as a way to cut costs

FDA panel to review heart drug strictly for African-Americans

Possible fifth case of brain infection linked to Tysabri

Senators question pharma companies on state educational grants

Raider storms Havas board, shadowing Euro RSCG Life

Drug costs up 10 percent, a figure lower than expected

Crawford cleared of affair allegations

Support for CME crosses $2-billion mark

FDA approves Viagra ingredient for pulmonary hypertension

Canada bill calls for ban on drug exports

Acomplia could reach sales of $3 billion per year

Spike seen in prices of several Rx pain drugs

Fleishman-Hillard launches managed-markets division

Novartis and travel-guide guru publish free bathroom book

Ogilvy Healthworld taps Rossetti to head U.S. business

Battered King picks new CFO after months of questions

People news from the 06/03/05 News Brief

Company News from the 06/03/05 News Brief

Lowe closes agency; Chairman blames loss of Xolair

Merck launches corporate ad blitz

Possible fourth death tied to Tysabri

Connelly to lead Lilly’s U.S. unit, joins elite group

Nearly half of drug postmarketing studies left unfinished

Takeda goes it alone with Ramelteon launch

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma.